Correspondence 0001104659-24-106225 from FG Merger II Corp. (FGMC, FGMCR, FGMCU) (CIK 0001906364) (FGMC)
FG Merger II Corp. (FGMC, FGMCR, FGMCU) (CIK 0001906364)
Date: Oct. 4, 2024 · CIK: 0001906364 · Accession: 0001104659-24-106225
AI Filing Summary & Sentiment
File numbers found in text: 333-275155
Referenced dates: September 23, 2024
Show Raw Text
CORRESP
1
filename1.htm
Giovanni Caruso
Partner
345 Park Avenue
New York, NY 10154
Direct 212.407.4866
Main 212.407.4000
Fax 212.937.3943
gcaruso@loeb.com
VIA EDGAR
October 4, 2024
Division of Corporation Finance
U.S. Securities & Exchange Commission
100 F Street, NE
Washington, D.C. 20549
Attention:
Ronald (Ron) E. Alper
Jeffrey Gabor
William Demarest
Shannon Menjivar
Re:
FG Merger II Corp.
Amendment No. 2 to Registration Statement
on Form S-1
Filed August 23, 2024
File No. 333-275155
Dear Mr. Danberg:
On behalf of our client, FG
Merger II Corp., a Nevada corporation (the “Company”), we hereby respond to the comments of the staff of the
Division of Corporation Finance of the Commission (the “Staff”) with respect to the above-referenced Registration
Statement on Form S-1 submitted on August 23, 2024 (the “Registration Statement”) contained in the
Staff’s letter dated September 23, 2024 (the “Comment Letter”).
The Company has filed via
EDGAR the Registration Statement on Form S-1 (the “Amended Registration Statement”), which reflects the
Company’s responses to the comments received by the Staff and certain updated information. For ease of reference, each comment contained
in the Comment Letter is printed below and is followed by the Company’s response. All page references in the responses set
forth below refer to the page numbers in the Registration Statement.
Amendment No. 2 to Registration Statement on Form S-1
filed August 23, 2024
Cover Page
1. Please state the amount of the compensation received or to be received by the SPAC sponsor, its affiliates, and promoters. Please
also revise to discuss whether the compensation to be paid and securities issued to the sponsor, its affiliates, and promoters, may result
in a material dilution of the purchasers’ equity interests. Please provide a cross-reference highlighted by prominent type or in
another manner, to all the sections in the prospectus for disclosures related to compensation. See Item 1602(a)(3) of Regulation
S-K.
Responses: The Company acknowledges the Staff’s
comment and has revised the disclosure on the cover page and on pages 12 and 92 of the Amended Registration Statement.
2. Please clearly state that there may be actual or potential material conflicts of interest between the sponsor, its affiliates,
or promoters as one group, and purchasers in the offering as another group. See Item 1602(a)(5) of Regulation S-K.
Responses: The Company acknowledges the Staff’s
comment and has revised the disclosure on the cover page and on pages 12 and 92 of the Amended Registration Statement.
Summary, page 1
3. We refer you to your tabular presentation of dilution at quartile intervals on the outside cover page and on pages 69
and 70. Such tabular presentation appears to assume your maximum redemption threshold is the entire amount of shares to be sold to public
shareholders as part of this offering. We further note your disclosure on page F-7 that you will proceed with a Business Combination
only if the Company has net tangible assets, after payment of the deferred underwriting fees, of at least $5,000,000 upon or immediately
prior to such consummation of a Business Combination. Please tell us how you considered this redemption restriction in your determination
of your maximum redemption threshold for your dilution presentation. Please refer to Item 1602 of Regulation S-K.
Responses: The Company acknowledges the Staff’s
comment and advises the Staff that the proposed amended and restated certificate of incorporation of the Company does not contain a minimum
net tangible assets requirement and, as such, the Company has deleted the language regarding net tangible assets on page F-7.
Prior SPAC Experience, page 7
4. When discussing involvement with other SPACs, please revise to balance your disclosure. For example, with respect to the completed
de-SPAC, please revise to disclose additional information regarding the de-SPAC transactions, including the financing needed for the transactions.
In addition, revise your disclosure here to discuss the high level of competition you may face in pursuing business combination transaction
candidates, which you discuss on page 34, and also explain that the competition may negatively impact the acquisition terms you are
able to negotiate.
Responses: The Company acknowledges the Staff’s
comment and has revised the disclosure on pages 8 and 88 of the Amended Registration Statement.
Initial Business Combination, page 9
5. We note that you may extend the time to complete a business combination beyond 24 months. Please also disclose that there is no
limit on the number of extensions that you may seek and that you do not expect to extend the time period to consummate our initial business
combination beyond 36 months from the closing of this offering, as disclosed on page 32. See Item 1602(b)(4) of Regulation S-K.
Responses: The Company acknowledges the Staff’s
comment and has revised the disclosure on pages 10, 30, 37, 89 and 100 of the Amended Registration Statement.
Sourcing of Potential Initial Business Combination Targets, page 10
6. Please revise the disclosures outside of the table to describe the extent to which the compensations and/or the conversion of the
working capital loans into private placement units may result in a material dilution of the purchasers' equity interests. See Item 1602(b)(6) of
Regulation S-K.
Responses: The Company acknowledges the Staff’s
comment and has revised the disclosure on pages 12and 92 of the Amended Registration Statement.
7. You state that you do not believe the fiduciary duties or contractual obligations of your officers or directors will materially
affect your ability to complete an initial business combination. We also note that you state that you expect to focus your search on businesses
in the financial services industry in North America. Please expand your disclosures to explain the basis for this belief, and in particular,
specifically address in your explanation Mr. Swets’ obligations to FG Merger III Corp. which in its initial public offering
registration statement, stated that it intends to focus its search for a target business in the financial services industry in North America.
We also note that FG Acquisition Corp., of which Mr. Swets is the CEO, indicates on its website that it intends to focus its search
for a target in the financial services sector.
Responses:
The Company acknowledges the Staff’s comment and has revised the disclosure on pages 13, 32, 52, 92 and 120 of the Amended
Registration Statement. In addition, the Company advises the Staff that FG Acquisition Corp. completed its business combination and is
no longer seeking a target.
Founder shares, page 16
8. Please revise to clarify whether the sponsor may receive additional securities pursuant to any anti-dilution adjustments.
Responses: The Company acknowledges the Staff’s
comment and has revised the disclosure on the cover page and pages 12, 19, 49, 60 and 92 of the Amended Registration Statement.
9. Please expand your disclosure here, and elsewhere as appropriate, including your risk factor on page 30, to clarify if any
public shares sold in this offering would be required to approve the business combination if the over-allotment option is exercised and
quorum is present at the meeting.
Responses: The Company acknowledges the Staff’s
comment and has revised the disclosure on pages 19, 26, 35, 98, and 132 of the Amended Registration Statement.
Conflicts of interest, page 28
10. Please revise your disclosure in this section to clearly state the conflicts with purchasers in the
offering. See Item 1602(b)(7) of Regulation S-K.
Responses: The Company acknowledges
the Staff’s comment and has revised the disclosure on page 31 of the Amended Registration Statement.
11. Please revise to clearly disclose the nominal price paid for the securities and the conflict of interest
in determining whether to pursue a de-SPAC transaction. See Item 1602(b)(7) of Regulation S-K.
Responses: The Company acknowledges
the Staff’s comment and has revised the disclosure on page 33 of the Amended Registration Statement.
Risk Factors, page 30
12. We note the disclosure on page 121 and elsewhere that in order to facilitate your initial business combination or a PIPE financing
or for any other reason determined by your sponsor in its sole discretion, your sponsor may surrender or forfeit, transfer or exchange
your founder shares, private placement units or any of your other securities, including for no consideration, as well as subject any such
securities to earn-outs or other restrictions, or otherwise amend the terms of any such securities or enter into any other arrangements
with respect to any such securities. Please add risk factor disclosure about risks that may arise from the sponsor having the ability
to remove itself as your sponsor before identifying a business combination, including through the unconditional ability to transfer the
founder shares or otherwise.
Responses: The Company acknowledges the Staff’s
comment and has revised the disclosure on page 48 of the Amended Registration Statement.
Dilution, page 68
13. Please revise to clarify whether one of the assumptions used to calculate dilution is that no additional securities will be issued
in connection with additional financing to facilitate an initial business combination. Please also expand your disclosure to highlight
that you may need to do so as you intend to seek an initial business combination with a target company with an enterprise value significantly
greater than the net proceeds of the offering and the sale of private units, as stated on page 11.
Responses: The Company acknowledges the Staff’s
comment and has revised the disclosure on page 73 of the Amended Registration Statement.
Proposed Business, page 85
14. Please revise the table on page 85 to disclose the lock-up agreement with the underwriter. See
Item 1603(a)(9) of Regulation S-K.
Responses: The Company acknowledges the Staff’s
comment and has revised the disclosure on pages 20 and 150 of the Amended Registration Statement.
Financial Statements
Note 2. Summary of Significant Accounting Policies
Deferred Offering
Costs, page F-9
15. We note your deferred offering costs include audit expense. Please tell us the nature and amount of the expense. Include within
your response how the company determined the expense represents a deferred offering cost and cite all relevant accounting literature within
your response.
Responses: The Company acknowledges the Staff’s
comment and advises the Staff that out of the total deferred offering costs of $114,670 recorded by the Company on the balance sheet date,
$9,000 relates to the audit fee for the period from September 20,2023 (inception) to October 10, 2023 which was incurred in
connection the preparation of the filing of the initial Registration Statement on Form S-1 for this offering. All future audit fees
will be immediately expensed as professional fees subsequent to the IPO, and the audit fee for the initial S-1 is the only incremental
audit cost associated with the offering.
The Company referred to SEC’s Codification of Staff
Accounting Bulletins – SAB Topic 5.A. Specific accounting cost related to a transaction are included in the deferred cost. As such,
the Company views the above described audit fee as a deferred cost given it specifically relates to filing of a Registration Statement
on S-1 in connection with an initial public offering.
Exhibits and Financial Statement Schedules
Amended and Restated Articles of Incorporation, page II-4
16. We note that the amended articles refer to a 15-month period to complete an initial business combination or 18 months if extended.
Please revise or advise.
Responses: The Company acknowledges the Staff’s
comment and has revised the Amended and Restated Articles of Incorporation to reflect that the Company will have 24 months to complete
a business combination.
Please do not hesitate to contact Giovanni
Caruso of Loeb & Loeb LLP at (212) 407-4866 with any questions or comments regarding this letter.
Sincerely,
/s/ Giovanni Caruso
Giovanni Caruso
Partner
cc: Robert I. Kauffman